Showing results (161-170 of 437) with videos related to
Sort By:
Pageof 44
Clinical Rheumatology|January 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)Ruediger B Mueller, Hendrik Schulze-Koops, Daniel E Furst, et al.Journal of Scleroderma and Related Disorders|May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II CohortSangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.RMD Open|January 31, 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysisPhilip J Mease, Soumya Reddy, Sarah Ross, et al.Journal of Clinical Epidemiology|November 13, 2015
Modified intention-to-treat analysis did not bias trial resultsAnna Dossing, Simon Tarp, Daniel E Furst, et al.Rheumatology International|February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.Rheumatology (Oxford, England)|February 11, 2015
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosisBeth Wallace, Suzanne Kafaja, Daniel E Furst, et al.The Journal of Rheumatology|June 3, 2015
Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life StudySarah D Mills, Rina S Fox, Erin L Merz, et al.The Journal of Rheumatology|January 14, 2004
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)Daniel E Furst, Michael H Schiff, Roy M Fleischmann, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 18, 2015
Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-AnalysisSarah S Thomas, Nabeel Borazan, Nashla Barroso, et al.Blood|September 28, 2002
Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answerNathalie C Lambert, Y M Dennis Lo, Timothy D Erickson, et al.Pageof 44